1Hosoki T, Yosioka Y, matsubara T, et al.Power Doppler sonography of hepatocellular carcinoma treated by transcatheter arterial chernoernbolization: Assessment of the therapeutic effect[J]. Acta Radiol,1999,40(6) :639-643.
2Okusaka T,Okada S,Ueno H,et al. Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma [J]. Oncology, 2000, 58 ( 4 )293-299.
3Castrucci M,Sironi S, De Cobelli F, et al.Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma trea-ted with transarterial chemoembolization[J]. Abdominal Imaging, 1996, 21 ( 6 )488-494.
4Katoh T, Mitani M, Noma K, et al. Delayed enhancement of hepatocellular carcinoma on dynamic CT: Sign of extrahepatic collaterals after transcatheter arterial chemoembolization or transcatheter arterial chemoinfusion[J]. Abdominal Imaging,2002,27(1) : 34-39.
5Sumi S, Yamashita Y, Mitsuzaki K, et al.Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma[J].AJR,1999,172(1) : 67-71.
6Tanaka K, Inoue S, Numata K, et al. Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization[J]. AJR,1992,158(3): 541-546.
8Numata K,Tanaka K,Kiba T,et al. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma[J]. AJR, 2001, 176(5):L1199-1205.
9Yoshioka H,Nakagawa K,Shindou H,et al. MR imaging of the liver before and after transcatheter hepatic chemo-embolization for hepatocellular carcinoma [J].Acta Radiologica, 1990,31 (1) : 63-67.
10Buckwalter KA, Ellis JH, Baker DE, et al. Pitfall in MR imaging of lymphadenopathy after lymphangiography[J]. Radiology, 1986,161 (3) : 831-832.
